Loading...

ADC Therapeutics SA (NYSE:ADCT)

8.02 USD +0.13 USD ( +1.65% )
Watchlist Manager
ADC Therapeutics SA
NYSE:ADCT
Watchlist

P/B
Price to Book Value

The Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.

P/B
=
Market Cap
/
Book Value of Equity
Current P/B
ADCT
3.8
Median P/B
ADCT
9.2
Industry P/B
Biotechnology
2.2

P/B History

Statistics
Price to Book Value

1 Year 3 Years 5 Years
Average 7.9 10.9 6.6
Median 7.7 9.2 6.3
Min 3.1 N/A N/A
Max 12.9 25 25

History Chart
Price to Book Value

P/B Forward Multiples

Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/B
N/A
2-Years Forward
P/B
N/A
3-Years Forward
P/B
N/A

P/B Across Competitors

ADCT Competitors
ADC Therapeutics SA Competitors

Country Company Market Cap P/B
CH
ADC Therapeutics SA
NYSE:ADCT
616M USD 3.8
US
Abbvie Inc
NYSE:ABBV
271B USD 16.6
US
Amgen Inc
NASDAQ:AMGN
131B USD 142.8
AU
CSL Ltd
ASX:CSL
130B AUD 6.4
US
Gilead Sciences Inc
NASDAQ:GILD
78.9B USD 4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
73.4B USD 6.7

Relative Valuation Report

View full relative valuation report for ADC Therapeutics SA, which takes into account all ADCT`s valuation multiples.

See Also

Similar Stocks